DE69941433D1 - Von protease typ ii spaltbares peptid - Google Patents
Von protease typ ii spaltbares peptidInfo
- Publication number
- DE69941433D1 DE69941433D1 DE69941433T DE69941433T DE69941433D1 DE 69941433 D1 DE69941433 D1 DE 69941433D1 DE 69941433 T DE69941433 T DE 69941433T DE 69941433 T DE69941433 T DE 69941433T DE 69941433 D1 DE69941433 D1 DE 69941433D1
- Authority
- DE
- Germany
- Prior art keywords
- tropoelastin
- amino acid
- derivatives
- protease
- molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108091005804 Peptidases Proteins 0.000 title abstract 4
- 239000004365 Protease Substances 0.000 title abstract 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 108010014258 Elastin Proteins 0.000 abstract 4
- 102100033167 Elastin Human genes 0.000 abstract 4
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 3
- 239000000816 peptidomimetic Substances 0.000 abstract 3
- 101000851054 Homo sapiens Elastin Proteins 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP4723A AUPP472398A0 (en) | 1998-07-17 | 1998-07-17 | Protease susceptibility II |
| PCT/AU1999/000580 WO2000004043A1 (en) | 1998-07-17 | 1999-07-19 | Protease susceptibility ii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69941433D1 true DE69941433D1 (de) | 2009-10-29 |
Family
ID=3808961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69941433T Expired - Lifetime DE69941433D1 (de) | 1998-07-17 | 1999-07-19 | Von protease typ ii spaltbares peptid |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7229788B1 (de) |
| EP (1) | EP1100815B1 (de) |
| JP (1) | JP4342731B2 (de) |
| AT (1) | ATE443076T1 (de) |
| AU (1) | AUPP472398A0 (de) |
| CA (1) | CA2335098C (de) |
| DE (1) | DE69941433D1 (de) |
| WO (1) | WO2000004043A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2393724B (en) * | 2002-10-01 | 2006-04-12 | Johnson & Johnson Medical Ltd | Controlled release therapeutic wound dressings |
| US8974803B2 (en) | 2009-03-10 | 2015-03-10 | The University Of Sydney | Injectable biomaterials |
| GB201102189D0 (en) * | 2011-02-08 | 2011-03-23 | King S College London | Materials and methods relating to cardiovascular imaging |
| KR20190040373A (ko) | 2011-09-30 | 2019-04-17 | 엘라스타겐 피티와이 리미티드 | 탄력섬유의 생체 내 합성 |
| FR2986233B1 (fr) * | 2012-02-01 | 2014-02-28 | Regentis Internat | Peptide bifonctionnel |
| US9688741B2 (en) | 2012-10-23 | 2017-06-27 | Elastagen Pty Ltd | Elastic hydrogel |
| CA2933047A1 (en) | 2012-12-10 | 2014-06-19 | Elastagen Pty Ltd | Scalable three-dimensional elastic construct manufacturing |
| WO2015021508A1 (en) | 2013-08-13 | 2015-02-19 | The University Of Sydney | Regeneration of damaged tissue |
| MX2016009817A (es) * | 2014-01-27 | 2017-02-28 | Auspex Pharmaceuticals Inc | Inhibidores de benzoquinolina del transportador vesicular de monoaminas 2. |
| US20190275087A1 (en) | 2018-03-01 | 2019-09-12 | Allergan Pharmaceuticals International Limited | Expansion and differentiation of stem cells |
| WO2020210440A1 (en) * | 2019-04-12 | 2020-10-15 | Geltor, Inc. | Recombinant elastin and production thereof |
| EP3962517A1 (de) | 2019-05-03 | 2022-03-09 | Allergan Pharmaceuticals International Limited | Vorbeugung und/oder behandlung von narben |
| AU2020338139A1 (en) | 2019-08-23 | 2022-04-07 | Allergan Pharmaceuticals International Limited | Tropoelastin for use in treatment of acne scarring |
| CA3162318A1 (en) * | 2019-12-18 | 2021-06-24 | Allergan Pharmaceuticals International, Ltd | Hybrid polymeric materials and uses thereof |
| US20230108501A1 (en) | 2020-02-06 | 2023-04-06 | Allergan Pharmaceuticals International Limited | Tissue engineering scaffolds |
| JP2023525155A (ja) | 2020-05-14 | 2023-06-14 | アラーガン ファーマシューティカルズ インターナショナル リミテッド | ヒアルロン酸に架橋したトロポエラスチンを含む組成物及びその使用方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2151883C (en) | 1992-12-22 | 2009-04-07 | Anthony Steven Weiss | Synthetic tropoelastin |
| US5726040A (en) | 1993-11-10 | 1998-03-10 | Ensley; Burt D. | Cosmetic compositions including tropoelastin isomorphs |
| US7001328B1 (en) * | 1994-11-15 | 2006-02-21 | Kenton W. Gregory | Method for using tropoelastin and for producing tropoelastin biomaterials |
| US6451326B2 (en) | 1996-05-02 | 2002-09-17 | Burt D. Ensley | Cosmetic compositions |
| AU728480B2 (en) | 1996-08-07 | 2001-01-11 | Hospital For Sick Children, The | Self-aligning peptides derived from elastin and other fibrous proteins |
| AU741851B2 (en) | 1997-07-18 | 2001-12-13 | Elastagen Pty Ltd | Tropoelastin derivatives |
| AUPO811797A0 (en) | 1997-07-18 | 1997-08-14 | University Of Sydney, The | Tropoelastin derivatives |
-
1998
- 1998-07-17 AU AUPP4723A patent/AUPP472398A0/en not_active Abandoned
-
1999
- 1999-07-19 AT AT99930951T patent/ATE443076T1/de not_active IP Right Cessation
- 1999-07-19 US US09/743,818 patent/US7229788B1/en not_active Expired - Lifetime
- 1999-07-19 JP JP2000560149A patent/JP4342731B2/ja not_active Expired - Lifetime
- 1999-07-19 EP EP99930951A patent/EP1100815B1/de not_active Expired - Lifetime
- 1999-07-19 WO PCT/AU1999/000580 patent/WO2000004043A1/en active IP Right Grant
- 1999-07-19 CA CA2335098A patent/CA2335098C/en not_active Expired - Lifetime
- 1999-07-19 DE DE69941433T patent/DE69941433D1/de not_active Expired - Lifetime
-
2007
- 2007-05-08 US US11/801,120 patent/US20080058261A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1100815B1 (de) | 2009-09-16 |
| JP2002520421A (ja) | 2002-07-09 |
| ATE443076T1 (de) | 2009-10-15 |
| US7229788B1 (en) | 2007-06-12 |
| JP4342731B2 (ja) | 2009-10-14 |
| EP1100815A1 (de) | 2001-05-23 |
| CA2335098A1 (en) | 2000-01-27 |
| EP1100815A4 (de) | 2005-05-25 |
| CA2335098C (en) | 2012-05-15 |
| US20080058261A1 (en) | 2008-03-06 |
| WO2000004043A1 (en) | 2000-01-27 |
| AUPP472398A0 (en) | 1998-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69941433D1 (de) | Von protease typ ii spaltbares peptid | |
| YU8997A (sh) | Prečišćen protein koji ima serinsku proteaznu inhibitorsku aktivnost i farmaceutski preparat koji ga sadrži | |
| MXPA03010079A (es) | Formulaciones de oxicodona de administracion una vez al dia. | |
| WO2001072977A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
| WO2002026947A3 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| WO2002042437A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
| WO2002034922A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
| WO2002046407A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| WO2002016566A3 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| WO2002050286A3 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| DE60120187D1 (de) | Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen | |
| WO2002077166A3 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| WO2001081412A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof | |
| WO2001081413A3 (en) | Isolated human transporter proteins, nucleic acids and uses thereof | |
| WO2002046406A3 (en) | Human transporter proteins, nucleic acid molecules encoding them,and uses thereof | |
| WO2002018554A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof | |
| WO2002050283A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
| WO2002033086A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| WO2002020757A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| WO2002024748A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| WO2002046217A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| DE60129228D1 (de) | Humane 7-transmembranproteine und dafür codierende polynukleotide | |
| WO2002057310A3 (en) | Human transporter proteins, nucleic acid molecules encoding them, and uses thereof | |
| WO2002024910A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof | |
| WO2001088136A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |